Dr
Adam
Hines

Patent Director

York Office

Telephone. +44(0) 1904 732 120
Mobile. +44(0) 776 639 2285
Email. [email protected]

Experience

Adam is a commercially-minded attorney with considerable experience of building, optimizing and defending patent portfolios.

Having previously managed an extensive patent portfolio at a multinational healthcare company, Adam is adept at developing harmonized, robust global IP strategies that complement the commercial goals of his clients and add value to their business.

European patent oppositions are a core aspect of Adam’s work. He has a wealth of knowledge in this area having represented clients at over 50 hearings before the European Patent Office both attacking and defending business-critical patents. Adam enjoys the challenging, dynamic and adversarial nature of the opposition process and has an established track record in achieving favourable outcomes for his clients.

Adam is dedicated to providing insightful and pragmatic advice to clients across a range of different industries and specializes in the field of medical technology and medical devices.

Specialisms

  • Drug delivery devices
  • Orthopaedics
  • Wound management

Industries

  • CleanTech icon CleanTech
  • Healthcare icon Healthcare
  • Medical devices icon Medical devices
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Designs & design rights
  • Due diligence
  • In-house legal support
  • Patent oppositions & appeals
  • Patents
  • Portfolio management
  • Searching & competitor monitoring
  • Strategy

Qualifications

Patent Attorney

Chartered (UK)
European


BSC

Chemistry with Medicinal Chemistry

MSC

Toxicology

PHD

PhD in Biochemistry and Environmental Metabolomics

Publications

The Internet of Medical Things

View publication online

Related News

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article

G1/21 hearing at the EPO

Follow this page for the updates from G1/21 hearing at the EPO on 28th May 2021. HGF Partners Dr Chris Moore and Douglas Drysdale will be reporting all the key …

Read article
Event - 9th June 2021

Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US

HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.